A Perspective piece reframed genomic sequencing’s next industry milestone around accessibility rather than only scaling throughput, usability, and integration. The report argues that sequencing has moved from high-cost, expert-only centers toward deployable infrastructure spanning population genomics, precision medicine, and clinical diagnostics—enabling participation from smaller institutions. It cites platform evolution from earlier large, capital-intensive systems to later high-throughput and lower-cost generations, including MGI’s G400 and G50 series and newer lines such as T20x2, T1+, and T7+. It also points to real-world deployment in challenging environments as evidence of broader operational reliability. The narrative aligns with MGI Tech’s 10th anniversary milestone, positioning reengineering for workflow simplicity and decentralized deployment as a decisive step for wider clinical adoption.